Voloridge Investment Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6M | Buy |
1,553,234
+37,620
| +2% | +$353K | 0.05% | 424 |
|
|
2025
Q1 | $10.8M | Sell |
1,515,614
-11,380
| -0.7% | -$80.9K | 0.04% | 551 |
|
|
2024
Q4 | $17.8M | Buy |
1,526,994
+1,059,751
| +227% | +$12.4M | 0.06% | 385 |
|
|
2024
Q3 | $9.6M | Buy |
467,243
+14,795
| +3% | +$304K | 0.03% | 597 |
|
|
2024
Q2 | $10.1M | Sell |
452,448
-343,066
| -43% | -$7.68M | 0.04% | 553 |
|
|
2024
Q1 | $21.9M | Buy |
795,514
+762,258
| +2,292% | +$21M | 0.08% | 310 |
|
|
2023
Q4 | $1.01M | Buy |
+33,256
| New | +$1.01M | ﹤0.01% | 942 |
|
|
2023
Q3 | – | Sell |
-72,443
| Closed | -$2.95M | – | 1540 |
|
|
2023
Q2 | $2.95M | Sell |
72,443
-10,996
| -13% | -$448K | 0.01% | 863 |
|
|
2023
Q1 | $3.11M | Buy |
83,439
+61,201
| +275% | +$2.28M | 0.02% | 833 |
|
|
2022
Q4 | $776K | Buy |
+22,238
| New | +$776K | ﹤0.01% | 1190 |
|
|
2022
Q3 | – | Sell |
-99,379
| Closed | -$5.14M | – | 1557 |
|
|
2022
Q2 | $5.14M | Buy |
99,379
+29,871
| +43% | +$1.55M | 0.03% | 665 |
|
|
2022
Q1 | $5.05M | Buy |
69,508
+19,023
| +38% | +$1.38M | 0.03% | 632 |
|
|
2021
Q4 | $5.97M | Sell |
50,485
-177,536
| -78% | -$21M | 0.03% | 652 |
|
|
2021
Q3 | $30.6M | Buy |
228,021
+124,418
| +120% | +$16.7M | 0.2% | 114 |
|
|
2021
Q2 | $16.8M | Buy |
+103,603
| New | +$16.8M | 0.12% | 228 |
|
|
2021
Q1 | – | Sell |
-4,868
| Closed | -$265K | – | 1572 |
|
|
2020
Q4 | $265K | Sell |
4,868
-20,572
| -81% | -$1.12M | ﹤0.01% | 1239 |
|
|
2020
Q3 | $506K | Buy |
+25,440
| New | +$506K | ﹤0.01% | 1086 |
|
|
2020
Q1 | – | Sell |
-20,382
| Closed | -$299K | – | 1300 |
|
|
2019
Q4 | $299K | Buy |
+20,382
| New | +$299K | 0.01% | 931 |
|
|
2019
Q3 | – | Sell |
-32,916
| Closed | -$539K | – | 1176 |
|
|
2019
Q2 | $539K | Buy |
+32,916
| New | +$539K | 0.01% | 550 |
|